We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Votes to Approve OSI's New Tarceva Indication
FDA Panel Votes to Approve OSI's New Tarceva Indication
September 16, 2005
An FDA advisory panel has recommended approving OSI Pharmaceuticals’ new indication for its cancer treatment Tarceva.